Your Location：Home >Products >Fine Chemicals >120511-73-1
Appearance:powder
Throughput:1|Metric Ton|Day
pd_productuse:intermediate
Delivery Time:in stock
Purity:99%
Anastrozole Basic information
Description Treatment for Early-stage Breast Cancer Uses Pharmacokinetics Indications and Usage Clinical Research
Product Name: Anastrozole
Synonyms: ICI-D-1033;ARIMIDEX;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;α，α，α’，α'-Tetramethyl-5-(1H-1，2，4-triazol-1-ylmethyl)-1，3-benzenediacetonitrile;2-[3-(2-Cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile;α1,α1,α3,α3-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile;Anastrozole(AriMidex);Anastrozole (200 mg)
CAS: 120511-73-1
MF: C17H19N5
MW: 293.37
EINECS: 601-715-6
Mol File: 120511-73-1.mol
Safety Information
Hazard Codes Xi,Xn
Risk Statements 36/37/38-22-61-60
Safety Statements 26-37/39
RIDADR 3249
WGK Germany 3
RTECS CZ1465000
HazardClass 6.1(b)
PackingGroup III
HS Code 29339980
Hazardous Substances Data 120511-73-1(Hazardous Substances Data)
CAS：885523-08-0
CAS：517920-73-9
CAS：4347-31-3
CAS：104010-37-9
